摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 1-tert-butyl-5-oxopyrrolidine-3-carboxylate | 59857-85-1

中文名称
——
中文别名
——
英文名称
methyl 1-tert-butyl-5-oxopyrrolidine-3-carboxylate
英文别名
1-tert.-Butyl-3-methoxycarbonyl-pyrrolidon-(5);Methyl N-t-butyl-5-oxo-3-pyrroldinylcarboxylat;1-tert-butyl-5-oxo-pyrrolidine-3-carboxylic acid methyl ester
methyl 1-tert-butyl-5-oxopyrrolidine-3-carboxylate化学式
CAS
59857-85-1
化学式
C10H17NO3
mdl
MFCD06804424
分子量
199.25
InChiKey
ZGVJCGNGCLAOIV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933790090

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 1-tert-butyl-5-oxopyrrolidine-3-carboxylate 在 lithium hydroxide monohydrate 、 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以100 mg的产率得到1-叔丁基-5-氧代吡咯烷-3-羧酸
    参考文献:
    名称:
    [EN] ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    [FR] DÉRIVÉS CYCLIQUES D'ARYLOXAZOLO EN SPIRALE POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
    摘要:
    本发明提供了具有一般式(I)的新化合物,其中Alto A4,Li,L2,R1和R2如本文所述,包括该化合物的组合物以及使用该化合物治疗乙型肝炎感染的方法。
    公开号:
    WO2022112140A1
  • 作为产物:
    描述:
    衣康酸二甲酯叔丁胺叔丁醇 为溶剂, 反应 18.0h, 以500 mg的产率得到methyl 1-tert-butyl-5-oxopyrrolidine-3-carboxylate
    参考文献:
    名称:
    [EN] ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    [FR] DÉRIVÉS CYCLIQUES D'ARYLOXAZOLO EN SPIRALE POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
    摘要:
    本发明提供了具有一般式(I)的新化合物,其中Alto A4,Li,L2,R1和R2如本文所述,包括该化合物的组合物以及使用该化合物治疗乙型肝炎感染的方法。
    公开号:
    WO2022112140A1
点击查看最新优质反应信息

文献信息

  • Cosmetic compositions comprising photostabilized dibenzoylmethane compounds and 2-pyrrolidinone-4- carboxy esters
    申请人:Richard Hervé
    公开号:US20100183529A1
    公开(公告)日:2010-07-22
    Photostable cosmetic compositions contain, formulated into a cosmetically acceptable vehicle, at least one UV-screening system that includes: (a) at least one dibenzoylmethane compound, and (b) at least one 2-pyrrolidinone-4-carboxy ester compound having the following formula (I): in which: R 1 is a linear or branched C 1 -C 20 alkyl radical, and R 2 is a linear or branched C 1 -C 20 alkyl radical which optionally includes a C 5 -C 6 ring member, the phenyl radical, the benzyl radical or the phenethyl radical.
    光稳定的化妆品组合物包含至少一种紫外线屏障系统,配制成化妆上可接受的载体,其中包括: (a) 至少一种二苯甲酮化合物,以及 (b) 具有以下式(I)的至少一种2-吡咯烷酮-4-羧酯化合物: 其中: R1是线性或支链的C1-C20烷基基团,以及 R2是线性或支链的C1-C20烷基基团,可选地包括一个C5-C6环成员,苯基基团,苄基基团或苯乙基基团。
  • COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES
    申请人:Richard Herve
    公开号:US20140294743A1
    公开(公告)日:2014-10-02
    The present invention relates to a cosmetic and/or dermatological composition comprising in a physiologically acceptable medium at least one merocyanine derivative of formula (1) or (2) and/or its E,E-, E,Z- or Z,Z-geometrical isomer forms: comprising specific polar groups consisting of hydroxyl- and ether-functionalities. Another object of the present invention relates to a cosmetic process for controlling and/or improving the darkening of the skin under exposure to UV radiation and the homogeneity of the colour of the complexion which comprises the application onto the skin of a cosmetic composition as above defined. Another object of the present invention relates to a cosmetic process for protecting the keratinic materials and particularly the skin against photo-ageing which comprises the application onto the keratinic material of a cosmetic composition as above defined.
    本发明涉及一种化妆品和/或皮肤科学组合物,其在生理上可接受的介质中包含至少一种公式(1)或(2)的merocyanine衍生物及/或其E,E-,E,Z-或Z,Z-几何异构体形式:包括由羟基和醚功能团组成的特定极性基团。本发明的另一个目的涉及一种化妆过程,用于控制和/或改善皮肤在紫外线照射下的变黑和肤色均匀性,包括在皮肤上涂抹上述定义的化妆品组合物。本发明的另一个目的涉及一种化妆过程,用于保护角质素材料,特别是皮肤免受光老化的影响,包括在角质素材料上涂抹上述定义的化妆品组合物。
  • Cosmetic compositions comprising 4-carboxy-2-pyrrolidinone esters and triazine lipophilic UV-screening agents
    申请人:Richard Hervé
    公开号:US20100183530A1
    公开(公告)日:2010-07-22
    UV-screening compositions, formulated into a cosmetically acceptable medium, contain at least one ester solvent derived from 4-carboxy-2-pyrrolidinone, of formula (I) below: in which: R 1 is a linear or branched C 1 -C 20 alkyl radical, R 2 is a linear or branched C 1 -C 20 alkyl radical that may contain a C 5 -C 6 ring member, the phenyl radical, the benzyl radical or the phenethyl radical, and at least one triazine-type lipophilic UV-screening agent.
    防紫外线配方,配制成化妆品可接受的介质,含有至少一种由4-羧基-2-吡咯烷酮衍生的酯溶剂,其化学式(I)如下:其中:R1是线性或支链C1-C20烷基基团,R2是线性或支链C1-C20烷基基团,可能包含C5-C6环成员,苯基基团,苄基基团或苯乙基基团,以及至少一种三嗪型亲脂性紫外线筛选剂。
  • COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A MEROCYANIN SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A MEROCYANIN SCREENING AGENT
    申请人:Richard Herve
    公开号:US20120269749A1
    公开(公告)日:2012-10-25
    The present invention relates to a composition comprising, in a cosmetically acceptable medium, at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I) below: in which: R 1 denotes a linear or branched C 1 -C 20 alkyl radical, R 2 denotes a linear or branched C 1 -C 20 alkyl radical that may contain a C 5 -C 6 ring, the phenyl radical, the benzyl radical or the phenethyl radical, and at least one merocyanin-type UV screening agent. The present invention also relates to the use of at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I), as defined above, in a composition comprising, in a cosmetically acceptable medium, at least one merocyanin-type UV screening agent, as a solvent for said merocyanin screening agent, in and/or as an agent for improving the solubility of said merocyanin screening agent in said composition or with the aim of improving the sun protection factor.
    本发明涉及一种组合物,该组合物在化妆上可接受的介质中包含至少一种来自4-羧基-2-吡咯烷酮的酯,其化学式(I)如下: 其中: R1表示线性或支链C1-C20烷基基团, R2表示线性或支链C1-C20烷基基团,可能包含C5-C6环,苯基基团,苄基基团或苯乙基基团, 以及至少一种美洛氰染料型UV筛选剂。 本发明还涉及使用上述定义的化学式(I)中的至少一种来自4-羧基-2-吡咯烷酮的酯,在化妆上可接受的介质中包含至少一种美洛氰染料型UV筛选剂的组合物中,作为上述美洛氰染料型筛选剂的溶剂,在/或作为改善上述美洛氰染料型筛选剂在该组合物中的溶解度或改善防晒系数的剂。
  • COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A LIPOPHILIC SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A BENZOPHENONE LIPOPHILIC SCREENING AGENT
    申请人:Richard Herve
    公开号:US20120269750A1
    公开(公告)日:2012-10-25
    The present invention relates to a composition comprising, in a cosmetically acceptable medium, at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I) below: in which: R 1 denotes a linear or branched C 1 -C 20 alkyl radical, R 2 denotes a linear or branched C 1 -C 20 alkyl radical that may contain a C 5 -C 6 ring, the phenyl radical, the benzyl radical or the phenethyl radical, and at least one benzophenone-type lipophilic UV screening agent. The present invention also relates to the use of at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I), as defined above, in a composition comprising, in a cosmetically acceptable medium, at least one benzophenone-type lipophilic UV screening agent, as a solvent for said benzophenone screening agent, in and/or as an agent for improving the solubility of said benzophenone screening agent in said composition or with the aim of improving the sun protection factor.
    本发明涉及一种组合物,包括至少一种来自4-羧基-2-吡咯酮的酯类,在化妆品接受的介质中,其化学式(I)如下: 其中: R1表示线性或支链的C1-C20烷基基团, R2表示线性或支链的C1-C20烷基基团,可能包含C5-C6环、苯基基团、苄基基团或苯乙基基团, 以及至少一种苯甲酰苯酮型亲脂性紫外线筛选剂。 本发明还涉及使用上述化学式(I)中至少一种来自4-羧基-2-吡咯酮的酯类,在化妆品接受的介质中,作为溶剂用于所述苯甲酰苯酮筛选剂,并/或作为改善所述化妆品中所述苯甲酰苯酮筛选剂的溶解度的剂,或旨在提高防晒系数。
查看更多

同类化合物

(2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁 阿维巴坦中间体1 阿曲生坦中间体 阿曲生坦 间甲氧基苯乙腈 铂(2+)羟基乙酸酯-吡咯烷-3-胺(1:1:1) 钾2-氧代吡咯烷-1-磺酸酯 钠1-[(9E)-9-十八碳烯酰基氧基]-2,5-二氧代-3-吡咯烷磺酸酯 金刚烷-1-基(吡咯烷-1-基)甲酮 酸-1-吡咯烷-1,4-氨基-2-甲基-1,1,1-二甲基乙基酯,(2S,4R)- 酚丙氢吡咯 试剂3-Mercaptopropanyl-N-hydroxysuccinimideester 西他利酮 血红素酸 螺虫乙酯残留代谢物Mono-Hydroxy 萘吡坦